MedPath

江西东抚制药有限公司

Ownership
-
Established
2015-05-22
Employees
-
Market Cap
-
Website
www.huiyinbi.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

12

NMPA:12

Drug Approvals

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20053505
Approval Date
Apr 18, 2024
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20053506
Approval Date
Apr 18, 2024
NMPA

Sterile Water for Injection

Product Name
灭菌注射用水
Approval Number
国药准字H20053538
Approval Date
Apr 18, 2024
NMPA

Levocarnitine Injection

Product Name
左卡尼汀注射液
Approval Number
国药准字H20113065
Approval Date
Apr 28, 2022
NMPA

Lincomycin Hydrochloride Injection

Product Name
盐酸林可霉素注射液
Approval Number
国药准字H20053528
Approval Date
Sep 4, 2020
NMPA

Sterile Water for Injection

Product Name
灭菌注射用水
Approval Number
国药准字H20053535
Approval Date
Sep 4, 2020
NMPA

Flucytosine Injection

Product Name
氟胞嘧啶注射液
Approval Number
国药准字H20033188
Approval Date
Sep 1, 2020
NMPA

Isosorbide Dinitrate and Sodium Chloride Injection

Product Name
硝酸异山梨酯氯化钠注射液
Approval Number
国药准字H19980047
Approval Date
Sep 1, 2020
NMPA

Citicoline Sodium and Glucose Injection

Product Name
德益荣
Approval Number
国药准字H20030488
Approval Date
Sep 1, 2020
NMPA

Tropisetron Citrate Injection

Product Name
枸橼酸托烷司琼注射液
Approval Number
国药准字H20100061
Approval Date
Mar 17, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.